The burden of lung disease

Thorax

Volumn 61, Issue 7, 2006, Pages 557-558

  Hubbard, R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CANCER MORTALITY; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HOSPITAL ADMISSION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; MORBIDITY; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; SLEEP APNEA SYNDROME; SOCIOECONOMICS; UNITED KINGDOM;

COST OF ILLNESS; GREAT BRITAIN; HUMANS; LUNG DISEASES; RESPIRATION DISORDERS;

EID: 33745852590     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.066050     Document Type: Editorial

References (12)

1. British Thoracic Society. The burden of lung disease: a statistical report from the British Thoracic Society, 2nd ed. London: British Thoracic Society, 2006.
2. Stradling JR, Crosby JH. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991;46:85-90.
3. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
4. Stradling JR, Davies RJ. Sleep-1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 2004;59:73-8.
5. Johnston I, Britton J, Kinnear W, et al. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301:1017-21.
6. Hubbard R, Johnston I, Coultas DB, et al. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996;51:711-0.
7. Royal College of Physicians. Nicotine addition in Britain. A report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians, 2000.
8. Gordon P, Sanders MH. Sleep-7: Positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax 2005;60:68-75.
9. Scott S, Walker P, Calverley PM. COPD exacerbations-4: Prevention. Thorax 2006;61:440-7.
10. Imperatori A, Harrison RN, Leitch DN, et al. Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax 2006;61:232-9.
11. Gleeson FV. Is screening for lung cancer using low dose spiral CT scanning worthwhile? Thorax 2006;61:5-7.
12. Partners in Cancer Research. Strategic analysis 2002: an overview of cancer research in the UK directly funded by NCRI partner organisations. London: NCRI, 2002.